Breast Video Channel
Explore the latest insights and summaries from experts in Breast.
Diagnostics & Biomarkers
Houston Methodist
Review and Updates of New and Upcoming Cytopathology Reporting Systems: 2024
FEATURING
Elizabeth M. Jacobi
- 10 views
- April 4, 2024
Nebraska Oncology Society
Optimizing Use of Axillary Ultrasound to Select Patients for Neoadjuvant BC Therapy
FEATURING
Olga Kantor
- 14 views
- April 10, 2024
London Breast Meeting
Updates in Systemic Therapy in mBC
FEATURING
Cornelia Leo
- 51 views
- April 16, 2024
- 1
London Breast Meeting
Intra-Operative Confirmation of Margins in Breast Conserving Surgery
FEATURING
Ashutosh Kothari
- 33 views
- April 16, 2024
- 1
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
State-of-the-Art Imaging for Brain Metastasis
FEATURING
Benjamin Ellingson
- 125 views
- April 30, 2024
- 1
University of Colorado Cancer Center
Young Women With HR+/HER2- Breast Cancer: Options for Risk Assessment
FEATURING
Virginia Borges
- 428 views
- May 1, 2024
- 3
Weill Cornell Medicine Oncology & Hematology
Inflammatory Breast Cancer - Diagnosis and Management Updates
FEATURING
Massimo Cristofanilli
- 497 views
- May 15, 2024
- 4
UChicago Medicine 12th International Clinical Cancer Genomics Conference
The Promise of Multi-Cancer Detection Assays
FEATURING
Peter Kuhn
- 103 views
- May 21, 2024
- 2
Lilly Medical Affairs
Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- MBC
FEATURING
Komal Jhaveri
- 931 views
- July 24, 2024
- 4
Lilly Medical Affairs
Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and Sequencing
FEATURING
Joyce O’Shaughnessy
- 1,788 views
- July 24, 2024
- 10
COR2ED The Heart of Medical Education
Treating ER+/HER2-Low mBC: 2L and Beyond
FEATURING
Aditya Bardia
- 247 views
- June 4, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
Development and Validation of RSClinN+ Tool for HR+/HER2- Node-Positive BC
FEATURING
Lajos Pusztai
- 836 views
- June 17, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Elucidating the Immune Active State of HR+/HER2- MammaPrint High 2 Early BC"
FEATURING
Erin Cobain
- 358 views
- June 18, 2024
- 3
ecancer
ASCO® 2024 Insights: "Clinical Behavior and Prognostic Impact of Genetic Testing in Young BRCA Breast Cancer Patients"
FEATURING
Matteo Lambertini
- 83 views
- July 2, 2024
- 1
Miami Cancer Institute Precision Oncology Symposium
Precision Therapy for HR+/HER2- mBC
FEATURING
Joyce O'Shaughnessy
- 517 views
- July 2, 2024
- 7
Fred Hutchinson Cancer Center
Biology and Clinical Relevance of ESR1 Mutation in Breast Cancer
FEATURING
Nancy Davidson
- 248 views
- August 2, 2024
- 2
Lajos Pusztai
Evaluating PCR as an Endpoint for Approving New Therapies in eBC
- 164 views
- August 9, 2024
- 2
Aurelio Castrellon
Prognostic Roles of AMH and ctDNA Detection in HR+/HER2- Node+ eBC
- 214 views
- August 20, 2024
- 4
Weill Cornell Medicine Oncology & Hematology
Defining High-Risk HR+/HER2- eBC: Clinical Pearls for Oncologists
FEATURING
Eleonora Nicolò
- 173 views
- August 22, 2024
- 1
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Updates in Early Stage BC
FEATURING
Frederick Howard
- 234 views
- August 26, 2024
Han-Byoel Lee
Identifying Breast Cancer Subtypes and Recurrence Risk: Multigene Assays in Treatment Decisions
- 326 views
- August 27, 2024
- 3
UChicago Medicine
Racial Disparities in Breast Cancer Screening and Diagnosis
FEATURING
Nan Chen
- 114 views
- August 29, 2024
Alessia Pellerino
Treatment Strategies for Leptomeningeal Disease in HER2+ mBC: Addressing Unmet Needs
- 163 views
- August 29, 2024
- 2
Cleveland Clinic Taussig Cancer Institute
Breast Imaging and the Young Patient
FEATURING
Laura Dean
- 206 views
- September 3, 2024
- 7
Cleveland Clinic Taussig Cancer Institute
Evaluation of a Polygenic Risk Score as a Predictor of Early Onset TNBC in Black Women
FEATURING
Holly Pederson
- 18 views
- September 11, 2024
Cleveland Clinic Taussig Cancer Institute
Genomic Landscape of Young and Older Onset Breast Cancer
FEATURING
Shimoli Barot
- 107 views
- September 11, 2024
Adam Brufsky
Brief Update on Genomic Assays for Early Stage Breast Cancer
- 454 views
- September 11, 2024
- 4
Houston Methodist
Novel Approaches in Oncology: Early Interception & BRCA Advances in Breast & Ovarian Cancer Therapy
FEATURING
Pamela Munster
- 28 views
- September 18, 2024
Oncology Data Advisor
AI Advancing Breast Cancer Detection: Insights From iCAD
FEATURING
Waqas Haque,
Dana Brown
- 19 views
- September 18, 2024
Shabnam Jaffer
The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: Best Practices
- 743 views
- September 23, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: ctDNA and Molecular Screening for Target Detection and Treatment Monitoring in mBC
FEATURING
Michail Ignatiadis
- 172 views
- September 26, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in mBC
FEATURING
Giampaolo Bianchini
- 535 views
- October 1, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing With Trastuzumab Deruxtecan in mBC
FEATURING
Paolo Tarantino
- 259 views
- October 1, 2024
- 4
Yale Cancer Center
Evaluating the Effectiveness of New Technologies in Breast Cancer Screening
FEATURING
Ilana Richman
- 39 views
- October 1, 2024
COR2ED The Heart of Medical Education
The Evolving Role of Liquid Biopsy With a Focus on NSCLC, BC, and CRC
FEATURING
Umberto Malapelle
- 283 views
- October 1, 2024
- 3
Houston Methodist
Interventional Breast Imaging: US, Stereo & MRI
FEATURING
Luz Venta
- 62 views
- October 8, 2024
- 2
Yale Cancer Center
Unraveling the Genetic Tapestry: Advances in Germline Testing
FEATURING
Veda Giri
- 22 views
- October 16, 2024
Fernanda Mosele
Trastuzumab Deruxtecan's Efficacy Across HER2 Expression Levels in mBC: Key Results From the DAISY Trial
- 373 views
- October 16, 2024
- 3
ecancer
ESMO 2024 Insights: ROME Basket Trial - Targeting Actionable Mutations vs. SoC in Pts With Advanced Solid Tumors
FEATURING
Andrea Botticelli
- 15 views
- October 22, 2024
Yale Cancer Center
HER2 Ultra-Low: Is It Real? A Close Look at Companion Diagnostics for Trastuzumab Deruxtecan (T-DXd) in Breast Cancer
FEATURING
David Rimm
- 119 views
- October 25, 2024
ecancer
Surveillance Imaging in Solid Tumors: More Complicated Than It Appears
FEATURING
Christopher Booth
- 240 views
- October 25, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Long-Term Outcomes and Treatment Strategies by ER Expression in Breast Cancer
FEATURING
Kazuki Nozawa
- 115 views
- October 29, 2024
Springer Healthcare IME
New Frontiers in Oncology: Advanced Diagnostics and Therapeutics
FEATURING
Solange Peters
- 179 views
- October 29, 2024
- 3
UCI Health
Advancing Breast Cancer Care With Liquid Biopsy Biomarkers
FEATURING
Ritesh Parajuli
- 5 views
- November 4, 2024
Sherry Yang
TAILORx Trial: Endocrine Therapy, 21-Gene Recurrence Score, and Clinical Outcomes in eBC
- 188 views
- November 20, 2024
- 2
Houston Methodist
BRCA2 Mutations and Hereditary Cancer Risk
FEATURING
Pamela Munster
- 63 views
- September 18, 2024
- 1
Cleveland Clinic Taussig Cancer Institute
Counseling Women With a Genetic Predisposition to Breast Cancer
FEATURING
Claudine Isaacs
- 50 views
- September 3, 2024
Yale Cancer Center
Individualizing Adjuvant Therapy for HR+/HER2- eBC
FEATURING
Anca Bulgaru
- 44 views
- November 25, 2024
- 1
UChicago Medicine
2024 Neoadjuvant IO Updates for HR+ BC
FEATURING
Gini Fleming
- 123 views
- March 1, 2024
- 1
Total Health
56 y/o Post-Menopausal Female With ER 90%, PR 70%, HER2-Neu Denovo mBC: Case Panel Discussion
- 113 views
- March 1, 2024
- 1
Total Health
Neoadjuvant ET for HR+ BC: Year in Review
FEATURING
Cynthia Ma
- 200 views
- March 2, 2024
- 3
Total Health
Cardio-Oncology in Breast Cancer: Treatment Options for Immune Checkpoint Inhibitors
FEATURING
Isaac Rhea
- 62 views
- March 6, 2024
- 1
Total Health
Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclines & HER2
FEATURING
Isaac Rhea
- 108 views
- March 6, 2024
- 1
Total Health
General Approach to Cardio-Oncology in Breast Cancer
FEATURING
Isaac Rhea
- 23 views
- March 6, 2024
GRACE
Early Diagnosis of Breast Cancer: Importance and Statistics
FEATURING
Doug Micalizzi
- 16 views
- April 2, 2024
Dana-Farber Cancer Institute
Concepts of Treatment, Progression, and Staging in mBC
FEATURING
Sarah Sammons
- 39 views
- April 2, 2024
UNC Lineberger Comprehensive Cancer Center
The Importance of Molecular Testing in HR+/HER2- mBC
FEATURING
Yara Abdou
- 382 views
- April 2, 2024
- 5
Nebraska Oncology Society
Optimizing Axillary Staging in Upfront Breast Cancer Surgery
FEATURING
Olga Kantor
- 46 views
- April 10, 2024
London Breast Meeting
Minimizing Morbidity in Axillary Lymph Node Dissection
FEATURING
Gemma Pons
- 32 views
- April 16, 2024
Everardo Saad
Surrogate Endpoints: Demystifying Their Role in Breast Cancer Research
- 24 views
- December 2, 2024
University of Illinois Cancer Center
Genetic Testing Insights: PRS, Germline Variant Detection, and Clonal Hematopoiesis
FEATURING
Kent Hoskins
- 11 views
- December 12, 2024
